The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Summary

The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Oncology
• Breast Cancer
• Prostate Cancer
• Gynecologic Cancer
• Brain Tumor
• Brain Cancer
• Gynecologic Tumor
• Prostate Tumor
• Prostate Neoplasm
• Breast Tumor
• Radiation Toxicity
• Quality of Life
• Rectal Cancer
• Rectal Tumor
• Rectal Neoplasms
• Lung Cancer
• Lung Tumor
• Lung Neoplasm
• Esophageal Cancer
• Esophagus Cancer
• Esophageal Tumor
• Esophageal Neoplasm
• Esophagus Tumor
• Esophagus Neoplasm
• Pancreatic Cancer
• Pancreatic Tumor
• Pancreatic Neoplasms
• Head and Neck Cancer
• Head and Neck Neoplasms
• Head and Neck Tumor
• Tumor
• Neoplasms
• Bladder Cancer
• Bladder Neoplasm
• Liver Cancer
• Liver Neoplasms
• Liver Metastases
• Oligometastases

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

18 years and older

Sex

All

Healthy volunteers

Not accepted

Sponsor

UMC Utrecht

Last updated on ClinicalTrials.gov

March 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites